MARATTO

review · Drug Development and Industrial Pharmacy

Nanoformulations in the treatment of lung cancer: current status and clinical potential

20245 citationsOpen accessAssiut University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Nanomedicines have opened up new possibilities for treating lung cancer. Focusing on tackling the challenges that hinder their clinical translation will promote the future of this area of endeavor.

Research topics

  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Inhalation and Respiratory Drug Delivery

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1080/03639045.2024.2437562

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.